MPIA
CRL icon

Mountain Pacific Investment Advisers’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-136,451
Closed -$20.5M 140
2025
Q1
$20.5M Sell
136,451
-2,159
-2% -$325K 1.53% 26
2024
Q4
$25.6M Sell
138,610
-669
-0.5% -$123K 1.8% 24
2024
Q3
$27.4M Sell
139,279
-2,803
-2% -$552K 1.87% 24
2024
Q2
$29.4M Sell
142,082
-1,842
-1% -$381K 2.19% 18
2024
Q1
$39M Buy
143,924
+1,020
+0.7% +$276K 2.18% 19
2023
Q4
$33.8M Buy
142,904
+9,723
+7% +$2.3M 2.09% 19
2023
Q3
$26.1M Buy
133,181
+8,821
+7% +$1.73M 1.81% 22
2023
Q2
$26.1M Buy
124,360
+14,775
+13% +$3.11M 1.75% 22
2023
Q1
$22.1M Buy
109,585
+2,514
+2% +$507K 1.57% 24
2022
Q4
$23.3M Buy
107,071
+17,170
+19% +$3.74M 1.69% 21
2022
Q3
$17.7M Buy
89,901
+16,056
+22% +$3.16M 1.38% 29
2022
Q2
$15.8M Buy
73,845
+222
+0.3% +$47.5K 1.2% 32
2022
Q1
$20.9M Buy
73,623
+959
+1% +$272K 1.37% 31
2021
Q4
$27.4M Buy
72,664
+1,799
+3% +$678K 1.61% 27
2021
Q3
$29.2M Buy
70,865
+12
+0% +$4.95K 1.79% 24
2021
Q2
$26.2M Buy
70,853
+165
+0.2% +$61K 1.65% 27
2021
Q1
$20.5M Buy
70,688
+5,060
+8% +$1.47M 1.36% 30
2020
Q4
$16.4M Buy
65,628
+351
+0.5% +$87.7K 1.17% 32
2020
Q3
$14.8M Buy
65,277
+55
+0.1% +$12.5K 1.21% 30
2020
Q2
$11.4M Buy
65,222
+57,312
+725% +$9.99M 1.01% 34
2020
Q1
$998K Buy
7,910
+1,222
+18% +$154K 0.1% 72
2019
Q4
$1.02M Sell
6,688
-559
-8% -$85.4K 0.09% 74
2019
Q3
$959K Sell
7,247
-6
-0.1% -$794 0.09% 74
2019
Q2
$1.03M Sell
7,253
-45
-0.6% -$6.38K 0.09% 70
2019
Q1
$1.06M Buy
7,298
+120
+2% +$17.4K 0.1% 68
2018
Q4
$812K Buy
7,178
+2,964
+70% +$335K 0.09% 68
2018
Q3
$567K Hold
4,214
0.05% 86
2018
Q2
$473K Buy
+4,214
New +$473K 0.05% 89